Luye Pharma Group Ltd

Detailed Description

Luye Pharma Group Ltd., an investment holding company, develops, produces, markets, and sells pharmaceutical products worldwide. The company offers Lipusu for ovarian cancer and treatment for metastatic carcinoma of ovary; CMNa, a chemical sensitizer for cancer radiotherapy; Tiandida for ovarian or non-small cell lung cancer; Tiandixin, a product used as an adjuvant therapy for malignant tumors, malignant hydrothorax and ascites, and respiratory infections; and Yitaida for acute promyelocytic leukemia and liver cancer. It also provides Rykindo, an injection for the treatment of acute and chronic schizophrenia; Seroquel and Seroquel XR for the treatment of schizophrenia and manic episodes of bipolar affective disorders; Rivastigmine Transdermal Patch for the treatment of Alzheimer's disease; Fentanyl Transdermal Patch for the treatment of cancer pain; and Buprenorphine Transdermal Patch for the treatment of chronic pain. In addition, it offers Beixi, an acarbose capsule for diabetes; Lutingnuo, a glutathione injection for toxicity and injuries caused by ionizing radiation; Beitangning, a pioglitazone hydrochloride capsule to control blood glucose; Nuosen for acute upper digestive tract hemorrhage; and Sailimai for the treatment of diarrhea. Further, it provides Xuezhikang, a lipid adjusting capsule; Maitongna for cerebral edema and swelling by trauma; Oulai, a compound sodium aescinate gel for local swelling; Oukai for the treatment of soft tissue swelling and venous edema; Fengshiye for patients who have pains in bones, joints, and limbs; Apleek Transdermal Patch for contraception; Sidinuo for osteoporosis; and glucosamine hydrochloride tablets for osteoarthritis. Additionally, it distributes and sells pharmaceutical drugs; and manufactures and sells of biopharmaceutical products. The company was founded in 1994 and is headquartered in Yantai, the People's Republic of China.

Financials